All stocks Β· HALEOSLABS
HL

HALEOS LABS LIMITED

HALEOSLABS BSE Biotechnology Healthcare

Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hyperten…

ISIN INE320X01016
Listed β€”
Quarters tracked 13
Filings 14 docs

About

Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.

Key Metrics

as of Sep 2026
Market Cap438 Cr
P/E27.70
Div Yield0.10 %
Book Valueβ‚Ή706.00
52w Highβ‚Ή1,778.00
52w Lowβ‚Ή1,084.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 67.83 63.38 80.72 77.84 79.04 85.43 82.88 78.50 86.57 86.37 71.23 67.84 74.56
Expenses 58.19 57.18 69.16 67.04 68.21 79.83 69.81 66.71 72.80 75.56 62.21 58.36 69.43
Operating Profit 9.64 6.20 11.56 10.80 10.83 5.60 13.07 11.79 13.77 10.81 9.02 9.48 5.13
OPM % 14.21 9.78 14.32 13.87 13.70 6.56 15.77 15.02 15.91 12.52 12.66 13.97 6.88
Other Income 0.46 0.97 0.08 0.44 1.01 2.20 0.06 1.26 0.43 2.28 0.64 0.33 0.58
Depreciation 3.01 2.66 2.69 2.68 2.63 2.62 2.56 2.57 2.50 2.62 2.55 2.55 2.53
Interest 1.81 1.34 1.46 1.51 1.73 1.84 1.96 1.92 2.16 2.56 2.04 2.48 1.82
Profit before tax 5.28 3.17 7.49 7.05 7.48 3.34 8.61 8.56 9.54 7.91 5.07 4.78 1.36
Tax % 38.64 29.65 27.77 29.36 31.02 19.76 27.64 29.79 32.29 24.91 34.71 34.73 48.53
Net Profit 3.24 2.23 5.41 4.98 5.16 2.68 6.23 6.01 6.46 5.93 3.31 3.12 0.70
EPS in Rs 10.72 7.38 17.89 16.47 17.07 8.86 20.61 19.88 21.37 19.61 10.95 10.32 2.32

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 301.00333.00300.00315.00346.00260.00257.00344.00213.00218.000.000.00
Expenses 261.00289.00265.00289.00314.00230.00233.00312.00200.00189.000.000.00
Operating Profit 40.0044.0035.0026.0031.0030.0024.0033.0013.0028.000.000.00
OPM % 13.0013.0012.008.009.0011.009.009.006.0013.00β€”β€”
Other Income 1.004.004.005.0014.001.002.002.003.002.000.000.00
Interest 6.008.009.005.005.005.005.005.004.006.000.000.00
Depreciation 11.0010.0010.008.008.007.007.006.006.006.000.000.00
Profit before tax 25.0030.0019.0018.0033.0019.0013.0024.006.0018.000.000.00
Tax % 29.0029.0032.0028.0023.0032.0031.0030.00-2.0030.00β€”β€”
Net Profit 18.0021.0013.0013.0025.0013.009.0017.006.0013.000.000.00
EPS in Rs 58.8170.6843.2343.7383.9543.5630.2655.0121.50β€”β€”β€”
Dividend Payout % 3.002.003.003.002.003.000.003.000.000.00β€”β€”

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 3.003.003.003.003.003.003.003.003.000.010.010.01
Reserves 212.00194.00173.00161.00148.00123.00110.00102.0085.0082.000.000.00
Borrowings 95.0082.0092.0087.0062.0045.0050.0047.0027.0026.000.000.00
Other Liabilities 94.0080.0080.0086.0099.00101.0066.0098.0061.0067.000.000.00
Total Liabilities 403.00358.00348.00337.00312.00272.00229.00251.00177.00175.000.000.00
Fixed Assets 190.00150.00138.00140.0099.00101.0094.0088.0069.0073.000.000.00
CWIP 1.000.006.001.0021.003.002.001.007.000.000.000.00
Investments 23.0023.0023.0023.0023.0026.0026.0026.005.000.000.000.00
Other Assets 189.00184.00181.00174.00169.00142.00106.00135.0095.00102.000.000.00
Total Assets 403.00358.00348.00337.00312.00272.00229.00251.00177.00175.000.000.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 38.0028.0015.005.00-15.0022.0014.0027.008.0020.000.000.00
Cash from Investing Activity -49.00-14.00-14.00-28.00-7.00-6.00-13.00-43.00-7.00-8.000.000.00
Cash from Financing Activity 11.00-14.00-1.0023.0015.00-8.00-2.0018.00-1.00-12.000.000.00
Net Cash Flow 0.000.000.00-1.00-8.008.00-1.002.000.000.000.000.00
Free Cash Flow -11.0014.001.00-24.00-30.0014.001.005.004.0012.000.000.00
CFO/OP % 111.0082.0051.0031.00-23.0088.0070.00103.0066.0087.00β€”β€”

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2015
Debtor Days 66.0071.0060.0053.0036.0042.0031.0039.0046.0065.00β€”
Inventory Days 183.00131.00168.00154.00143.00154.00138.00117.00135.00133.00β€”
Days Payable 141.0099.00111.00105.00124.00147.0091.00133.00122.00168.00β€”
Cash Conversion Cycle 108.00102.00116.00102.0054.0048.0078.0023.0060.0030.00β€”
Working Capital Days 57.0057.0061.0065.0044.0031.0027.0020.0041.0043.00β€”
ROCE % 11.0014.0011.009.0013.0014.0012.0022.009.0046.000.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 72.10 72.10 71.79 71.40 71.40 71.40 71.40 71.40 71.40 71.19 70.68 70.32
FIIs 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.02 0.01 0.00 0.00 0.00
DIIs 0.31 0.30 0.29 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 27.58 27.59 27.91 28.57 28.56 28.60 28.59 28.57 28.59 28.81 29.31 29.68
No. of Shareholders 6,859 6,937 7,125 7,521 7,412 7,479 7,626 7,849 7,861 8,116 8,233 8,443

Corporate Actions

7 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 24 Sep 2025 24 Sep 2025 β€” 1.50
Dividend 23 Sep 2024 23 Sep 2024 β€” 1.50
Dividend 22 Sep 2023 β€” β€” 1.50
Dividend 22 Sep 2022 β€” β€” 1.50
Dividend 20 Sep 2021 β€” β€” 1.50
Dividend 19 Sep 2019 β€” β€” 1.50
Other 12 Sep 2018 β€” β€” β€” Annual General Meeting

Announcements

5 filings